Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1996
12/03/1996US5580852 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
12/03/1996US5580788 Use of immunoglogulin-binding artificial proteins as molecular weight markers
12/03/1996US5580787 Nontoxic food starter culture
12/03/1996US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
12/03/1996US5580778 Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
12/03/1996US5580777 Generation of neural precursor cell lines
12/03/1996US5580776 Having genetic material stably incorporated
12/03/1996US5580775 Excitatory amino acid neurotransmission in cns synapses
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580773 Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
12/03/1996US5580771 Phosphodiesterases catalyze hydrolysis of cyclic nucleotides, and control cellular concentration of cyclic nucleotides
12/03/1996US5580769 Antiviral protein secreted by peripheral blood lymphocytes which inhibits replication of retroviruses including human immunodeficiency virus
12/03/1996US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages
12/03/1996US5580761 Method of conferring resistance to immunodeficiency viral infection
12/03/1996US5580760 FUSE binding protein and cDNA therefor
12/03/1996US5580758 For insertion into gene which expresses protein secretion in bordetello
12/03/1996US5580757 Culturing mammalian cell transformed with recombinant vector including nucleotide sequence encoding cleavage site sandwiched between galactosidase and protein a coding sequences, recovering expressed fusion protein, cleaving
12/03/1996US5580756 Ligand which is reactive with the cd28 receptor on t cells
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
12/03/1996US5580748 Measuring the presence or absence of a particular potassium channel; assessing the effect of poassium channel blockers on intracellular calcium levels; and, measuring activated intracellular calcium release
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580738 Delta-like gene expressed in neuroendocrine tumors
12/03/1996US5580737 High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
12/03/1996US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene
12/03/1996US5580727 Amli-MTg8 fusion protein resulting from T(8;21) translocation in acute myeloid leukemia
12/03/1996US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones
12/03/1996US5580722 Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
12/03/1996US5580720 Human lymphoid cells expressing human immunodeficiency virus envelope protein gp160
12/03/1996US5580719 Isolating genomic rna from poliovirus, employing rna sequencing to determine nucleotide at position 2493
12/03/1996US5580718 Oligonucleotides
12/03/1996US5580717 Recombinant library screening methods
12/03/1996US5580716 Parasite-derived resistance
12/03/1996US5580712 Silver halide emulsions, elements and methods of making same using synthetic biopolymer peptizers
12/03/1996US5580703 Human adeno-associated virus integration site DNA and uses thereof
12/03/1996US5580564 A pseudorabies virus having the replacement of the inducible promoter sequence of the immediate early gene to control tissue specificity; vaccines
12/03/1996US5580563 Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
12/03/1996US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
12/03/1996US5580559 Hybrid plasminogen activator
12/03/1996CA2177883A1 Polypeptides, their production and use
12/03/1996CA2075833C Neuropeptide control of ocular growth
12/03/1996CA2036997C Leu3a binding peptides
12/03/1996CA1338771C Adhesion receptor for laminin and its use
12/03/1996CA1338770C Vinyl substituted radiohalogen conjugates for protein labeling
12/01/1996CA2176417A1 Quinidine immunoassay and reagents
11/1996
11/28/1996WO1996037776A1 Functional ligands for the axonal cell recognition molecule contactin
11/28/1996WO1996037775A1 Methods for g protein coupled receptor activity screening
11/28/1996WO1996037625A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
11/28/1996WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines
11/28/1996WO1996037621A2 Multimeric proteins
11/28/1996WO1996037618A1 Chimeric proteins activating polymerase iii transcription, use thereof for detecting and analysing protein-protein interactions and genes coding for said proteins
11/28/1996WO1996037616A1 Alphavirus rna replicon systems
11/28/1996WO1996037615A1 Maize gene and protein for insect control
11/28/1996WO1996037614A1 Gene and protein for modification of the gravitropic response
11/28/1996WO1996037613A1 Gene controlling senescence in plants
11/28/1996WO1996037612A1 Transgenic animal models for type ii diabetes mellitus
11/28/1996WO1996037611A1 Eb1 gene product binds to apc
11/28/1996WO1996037610A2 Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
11/28/1996WO1996037609A1 A gene switch comprising an ecdysone receptor
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037607A2 Nucleic acid with a polymorphic domain of a b2 bradykinin receptor gene
11/28/1996WO1996037606A1 Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv)
11/28/1996WO1996037517A1 Rhesus ob protein and dna
11/28/1996WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/28/1996WO1996037515A1 Process of high purity albumin production
11/28/1996WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency
11/28/1996WO1996037513A1 cDNA CLONES ENCODING HUMAN G PROTEIN η SUBUNITS
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037235A1 Methods for inhibition of hiv
11/28/1996WO1996037225A1 Method for treatment of sle
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037221A1 Subunit vaccine against flavivirus infection
11/28/1996WO1996037220A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
11/28/1996WO1996037219A1 Abundant extracellular products and methods for their production and use
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037212A1 POLYPEPTIDE COMPOUNDS THAT FORM β SHEETS
11/28/1996WO1996037211A1 Latent transcripts and promoters of cytomegalovirus
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996WO1996037107A1 Antigen-specific activation of unprimed cd8+ t cells
11/28/1996WO1996037094A1 Process for the preparation of antiviral plant transformed with lactoferrin gene
11/28/1996WO1996032468A3 Bioprocess for production of dipeptide based compounds
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996WO1996029406A3 Nuclear localization factor associated with circadian rhythms
11/28/1996WO1996029405A3 Modulators of ob gene and screening methods therefor
11/28/1996WO1996027015A3 A novel gene for a protein kinase associated with drug resistance
11/28/1996WO1996023883A3 Modified ligands for receptor tyrosine kinases
11/28/1996WO1996022067A3 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
11/28/1996WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
11/28/1996DE19619255A1 Human cytomegalovirus peptide(s)
11/28/1996CA2222055A1 Multimeric proteins
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221824A1 Rhesus ob protein and dna
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221783A1 Cdna clones encoding human g protein .gamma. subunits
11/28/1996CA2221708A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
11/28/1996CA2221159A1 Eb1 gene product binds to apc
11/28/1996CA2221155A1 Cdna clone for south african arbovirus no. 86
11/28/1996CA2220415A1 Latent transcripts and promoters of cytomegalovirus
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
1 ... 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 ... 2916